[1]
2024. Soluble ST2 and its relation to inflammatory, vascular atherosclerotic, and calcification markers in patients with atrial fibrillation or heart failure at moderate-to-high cardiovascular risk. Eastern Journal of Medical Sciences. 7, 2 (Feb. 2024), 37–43. DOI:https://doi.org/10.32677/ejms.v7i2.3492.